Literature DB >> 19818452

Cardiomyopathies in propionic aciduria are reversible after liver transplantation.

Stéphane Romano1, Vassili Valayannopoulos, Guy Touati, Jean-Pierre Jais, Daniel Rabier, Yves de Keyzer, Damien Bonnet, Pascale de Lonlay.   

Abstract

OBJECTIVE: To evauluate the relationship between propionic acidemia (PA) and cardiomyopathy. STUDY
DESIGN: We retrospectively compared clinical and metabolic results of patients with PA with and without cardiomyopathy.
RESULTS: Of 26 patients with PA who survived the first year of age, a dilated cardiomyopathy developed in 6 (group 1) at a median age of 7 years (range, 5-11 years). They were compared with 14 patients without cardiomyopathy for whom data were available (group 2). Their median age at the time of the study was 11 years (range, 3-21 years). PA was diagnosed in the neonatal period in 5 of 6 patients in group 1 and 11 of 14 patients in group 2. All patients received similar medical treatment. Two patients in group 1 died of cardiac arrest. In 2 patients, the cardiomyopathy was reversed during the year after orthotopic liver transplantation (OLT). In 2 other patients, OLT was contraindicated because of severe heart disease. The number of metabolic distress episodes was similar in both groups. Excretion of propionate metabolites in urine did not correlate with the occurrence of cardiomyopathy.
CONCLUSION: Dilated cardiomyopathy, a frequent complication of PA, develops independent of any specific metabolic profile and is reversible after OLT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19818452     DOI: 10.1016/j.jpeds.2009.07.002

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  32 in total

1.  Delayed enhancement cardiac magnetic resonance imaging in propionic acidemia.

Authors:  Satoru Iwashima; Takamichi Ishikawa; Takehiko Ohzeki; Yusaku Endou
Journal:  Pediatr Cardiol       Date:  2010-05-19       Impact factor: 1.655

2.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.

Authors:  Stefan Kölker; Vassili Valayannopoulos; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; S P Nikolas Boy; Marlene Bøgehus Rasmussen; Peter Burgard; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Francesca Furlan; Florian Gleich; Maria Julieta González; Wanda Gradowska; Stephanie Grünewald; Tomas Honzik; Friederike Hörster; Hariklea Ioannou; Anil Jalan; Johannes Häberle; Gisela Haege; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Elaine Murphy; Hélène Ogier de Baulny; Carlos Ortez; Consuelo C Pedrón; Guillem Pintos-Morell; Luis Pena-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Allan M Lund; Angeles Garcia-Cazorla; Angeles Garcia Cazorla
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

3.  Impact of age at onset and newborn screening on outcome in organic acidurias.

Authors:  Jana Heringer; Vassili Valayannopoulos; Allan M Lund; Frits A Wijburg; Peter Freisinger; Ivo Barić; Matthias R Baumgartner; Peter Burgard; Alberto B Burlina; Kimberly A Chapman; Elisenda Cortès I Saladelafont; Daniela Karall; Chris Mühlhausen; Victoria Riches; Manuel Schiff; Jolanta Sykut-Cegielska; John H Walter; Jiri Zeman; Brigitte Chabrol; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2015-12-21       Impact factor: 4.982

4.  Inter-relations between 3-hydroxypropionate and propionate metabolism in rat liver: relevance to disorders of propionyl-CoA metabolism.

Authors:  Kirkland A Wilson; Yong Han; Miaoqi Zhang; Jeremy P Hess; Kimberly A Chapman; Gary W Cline; Gregory P Tochtrop; Henri Brunengraber; Guo-Fang Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-20       Impact factor: 4.310

5.  Ebstein cardiac anomaly, functional pulmonary atresia and isovaleric acidemia: A case report.

Authors:  Ammar M H Qadi; Hussam K Hamadah; Abdulraouf M Z Jijeh; Omar M Hijazi; Mohamad S Kabbani
Journal:  J Saudi Heart Assoc       Date:  2014-01-21

6.  Metabolic cardiomyopathy from propionic acidemia precipitating cardiac arrest in a 25-year-old man.

Authors:  Nigel S Tan; Ravi R Bajaj; Chantal Morel; Sheldon M Singh
Journal:  CMAJ       Date:  2018-07-23       Impact factor: 8.262

Review 7.  Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation.

Authors:  Stefan Kölker; Peter Burgard; Sven W Sauer; Jürgen G Okun
Journal:  J Inherit Metab Dis       Date:  2013-03-20       Impact factor: 4.982

8.  Clinical characteristics and mutation analysis of propionic acidemia in Thailand.

Authors:  Nithiwat Vatanavicharn; Somporn Liammongkolkul; Osamu Sakamoto; Mahattana Kamolsilp; Achara Sathienkijkanchai; Pornswan Wasant
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

9.  Autism spectrum disorders in propionic acidemia patients.

Authors:  Caroline Dejean de la Bâtie; Valérie Barbier; Célina Roda; Anaïs Brassier; Jean-Baptiste Arnoux; Vassili Valayannopoulos; Anne-Sophie Guemann; Clément Pontoizeau; Stéphanie Gobin; Florence Habarou; Florence Lacaille; Jean-Paul Bonnefont; Pierre Canouï; Chris Ottolenghi; Pascale De Lonlay; Lisa Ouss
Journal:  J Inherit Metab Dis       Date:  2017-08-30       Impact factor: 4.982

10.  Propionic acidemia as a cause of adult-onset dilated cardiomyopathy.

Authors:  Moniek Riemersma; Mark R Hazebroek; Appolonia T J M Helderman-van den Enden; Gajja S Salomons; Sacha Ferdinandusse; Martijn C G J Brouwers; Liesbeth van der Ploeg; Stephane Heymans; Jan F C Glatz; Arthur van den Wijngaard; Ingrid P C Krapels; Jörgen Bierau; Han G Brunner
Journal:  Eur J Hum Genet       Date:  2017-08-30       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.